Craniofacial fibrous dysplasia.

Area of Science:

• Medical research
• Genetics
• Pathophysiology

Background:

• Fibrous dysplasia (FD) is a rare bone disorder.
• Recent advances have improved understanding of FD's natural history and molecular basis.
• Significant questions persist regarding FD progression and management, particularly for craniofacial FD (CFD).

Purpose of the Study:

• To highlight the need for improved understanding of pathophysiologic mechanisms in FD phenotypes.
• To identify predictors for varying behaviors of FD lesions.
• To emphasize the importance of long-term follow-up for CFD patients due to unpredictable disease courses.

Main Methods:

• Literature review on fibrous dysplasia.
• Analysis of existing clinical data on craniofacial FD.
• Synthesis of current knowledge on FD pathophysiology and patient outcomes.

Main Results:

• Craniofacial FD (CFD) is generally slow-growing and asymptomatic without comorbidities.
• The pathophysiologic mechanisms driving diverse FD phenotypes require further elucidation.
• Predictors for the varied behaviors of FD lesions are not well-established.

Conclusions:

• Long-term follow-up is crucial for managing CFD due to its unpredictable nature.
• Further research is needed to understand FD mechanisms and improve patient management strategies.
• Spontaneous recovery from CFD is unlikely, underscoring the need for ongoing clinical attention.